Chargement en cours...
Oral Disease-Modifying Therapies for Multiple Sclerosis
Classical multiple sclerosis (MS) treatments using first-line injectable drugs, although widely applied, remain a major concern in terms of therapeutic adherence and efficacy. New oral drugs recently approved for MS treatment represent significant advances in therapy. The oral route of administratio...
Enregistré dans:
| Publié dans: | J Clin Neurol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Korean Neurological Association
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4302185/ https://ncbi.nlm.nih.gov/pubmed/25628732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3988/jcn.2015.11.1.9 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|